James Mond
2014
In 2014, James Mond earned a total compensation of $606.2K as Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 89% increase compared to previous year.
Compensation breakdown
| Bonus | $125,125 |
|---|---|
| Option Awards | $149,800 |
| Salary | $323,460 |
| Other | $7,800 |
| Total | $606,185 |
Mond received $323.5K in salary, accounting for 53% of the total pay in 2014.
Mond also received $125.1K in bonus, $149.8K in option awards and $7.8K in other compensation.
Rankings
In 2014, James Mond's compensation ranked 9,633rd out of 13,032 executives tracked by ExecPay. In other words, Mond earned more than 26.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,633 out of 13,032 | 26th |
Division Manufacturing | 3,642 out of 4,966 | 27th |
Major group Chemicals And Allied Products | 1,240 out of 1,686 | 27th |
Industry group Drugs | 983 out of 1,365 | 28th |
Industry Biological Products, Except Diagnostic Substances | 177 out of 236 | 25th |
Source: SEC filing on April 29, 2016.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2014.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019